InsidersTradesSigma
Follow the Indoco Remedies share price and the full directors' dealings record of the company, a listed issuer based in India. Shares are quoted on the IN market, under the supervision of SEBI (PIT + SAST). The latest transaction was reported on 31 August 2026 (Acquisition). Among the most active insiders: ADITI M. PANANDIKAR. All data is free.
2
Insider Decl.
n/a
Thresholds
€22,124
2 ops.
Buy Volume
n/a
n/a
Sell Volume
35Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 31 August 2026
Declarations2 total
5,000 shares@ ₹244.80100.0% of flowEquityMarket PurchaseSEBI:4e4ee6c5dffe21ae7ab420976d3a8368816b1e63
Canonical exit: 29 Nov 2026 (T+90)
5,000 shares@ ₹244.80100.0% of flowEquityMarket PurchaseSEBI:53c9daad1c3cbe91081feee40aeab91d13f6a89c
Canonical exit: 29 Nov 2026 (T+90)
2 of 2 declarations
About Indoco Remedies
Indoco Remedies is an Indian pharmaceutical company specializing in the manufacture of generic drugs and health products. It is listed on the Bombay Stock Exchange.